BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1274 related articles for article (PubMed ID: 33963333)

  • 21. Involvement of TLR2 and TLR4 in inflammatory immune responses induced by fine and coarse ambient air particulate matter.
    Shoenfelt J; Mitkus RJ; Zeisler R; Spatz RO; Powell J; Fenton MJ; Squibb KA; Medvedev AE
    J Leukoc Biol; 2009 Aug; 86(2):303-12. PubMed ID: 19406832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV.
    Sheahan T; Morrison TE; Funkhouser W; Uematsu S; Akira S; Baric RS; Heise MT
    PLoS Pathog; 2008 Dec; 4(12):e1000240. PubMed ID: 19079579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CCR2 Signaling Restricts SARS-CoV-2 Infection.
    Vanderheiden A; Thomas J; Soung AL; Davis-Gardner ME; Floyd K; Jin F; Cowan DA; Pellegrini K; Shi PY; Grakoui A; Klein RS; Bosinger SE; Kohlmeier JE; Menachery VD; Suthar MS
    mBio; 2021 Dec; 12(6):e0274921. PubMed ID: 34749524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammatory Response in COVID-19 Patients Resulting from the Interaction of the Inflammasome and SARS-CoV-2.
    Cheon SY; Koo BN
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenovirus vector-induced innate inflammatory mediators, MAPK signaling, as well as adaptive immune responses are dependent upon both TLR2 and TLR9 in vivo.
    Appledorn DM; Patial S; McBride A; Godbehere S; Van Rooijen N; Parameswaran N; Amalfitano A
    J Immunol; 2008 Aug; 181(3):2134-44. PubMed ID: 18641352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of HMGB1 in COVID-19-induced cytokine storm and its potential therapeutic targets: A review.
    Wulandari S; Hartono ; Wibawa T
    Immunology; 2023 Jun; 169(2):117-131. PubMed ID: 36571562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-6, CXCL10 and Infiltrating Macrophages in COVID-19-Related Cytokine Storm: Not One for All But All for One!
    Coperchini F; Chiovato L; Rotondi M
    Front Immunol; 2021; 12():668507. PubMed ID: 33981314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages.
    Pantazi I; Al-Qahtani AA; Alhamlan FS; Alothaid H; Matou-Nasri S; Sourvinos G; Vergadi E; Tsatsanis C
    Front Immunol; 2021; 12():683800. PubMed ID: 34248968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
    J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TLR3-Dependent Activation of TLR2 Endogenous Ligands via the MyD88 Signaling Pathway Augments the Innate Immune Response.
    Teixeira HS; Zhao J; Kazmierski E; Kinane DF; Benakanakere MR
    Cells; 2020 Aug; 9(8):. PubMed ID: 32824595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The herpes simplex virus 1-encoded envelope glycoprotein B activates NF-κB through the Toll-like receptor 2 and MyD88/TRAF6-dependent signaling pathway.
    Cai M; Li M; Wang K; Wang S; Lu Q; Yan J; Mossman KL; Lin R; Zheng C
    PLoS One; 2013; 8(1):e54586. PubMed ID: 23382920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acylation determines the toll-like receptor (TLR)-dependent positive versus TLR2-, mannose receptor-, and SIGNR1-independent negative regulation of pro-inflammatory cytokines by mycobacterial lipomannan.
    Doz E; Rose S; Nigou J; Gilleron M; Puzo G; Erard F; Ryffel B; Quesniaux VF
    J Biol Chem; 2007 Sep; 282(36):26014-25. PubMed ID: 17617634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defining the Innate Immune Responses for SARS-CoV-2-Human Macrophage Interactions.
    Abdelmoaty MM; Yeapuri P; Machhi J; Olson KE; Shahjin F; Kumar V; Zhou Y; Liang J; Pandey K; Acharya A; Byrareddy SN; Mosley RL; Gendelman HE
    Front Immunol; 2021; 12():741502. PubMed ID: 34671355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2 multifaceted interaction with the human host. Part II: Innate immunity response, immunopathology, and epigenetics.
    Beacon TH; Su RC; Lakowski TM; Delcuve GP; Davie JR
    IUBMB Life; 2020 Nov; 72(11):2331-2354. PubMed ID: 32936531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In Vivo Role of TLR2 and MyD88 Signaling in Eliciting Innate Immune Responses in Staphylococcal Endophthalmitis.
    Talreja D; Singh PK; Kumar A
    Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1719-32. PubMed ID: 25678692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pyroptotic macrophages stimulate the SARS-CoV-2-associated cytokine storm.
    Zhang J; Wu H; Yao X; Zhang D; Zhou Y; Fu B; Wang W; Li H; Wang Z; Hu Z; Ren Y; Sun R; Tian Z; Bian X; Wei H
    Cell Mol Immunol; 2021 May; 18(5):1305-1307. PubMed ID: 33742186
    [No Abstract]   [Full Text] [Related]  

  • 37. Mathematical Modeling of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Network with Cytokine Storm, Oxidative Stress, Thrombosis, Insulin Resistance, and Nitric Oxide Pathways.
    Sasidharakurup H; Kumar G; Nair B; Diwakar S
    OMICS; 2021 Dec; 25(12):770-781. PubMed ID: 34807729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TLRs: Innate Immune Sentries against SARS-CoV-2 Infection.
    Mantovani S; Oliviero B; Varchetta S; Renieri A; Mondelli MU
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Promising drug repurposing approach targeted for cytokine storm implicated in SARS-CoV-2 complications.
    Shawki MA; Elsayed NS; Mantawy EM; Said RS
    Immunopharmacol Immunotoxicol; 2021 Aug; 43(4):395-409. PubMed ID: 34057871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exhausted NK cells and cytokine storms in COVID-19: Whether NK cell therapy could be a therapeutic choice.
    Ghasemzadeh M; Ghasemzadeh A; Hosseini E
    Hum Immunol; 2022 Jan; 83(1):86-98. PubMed ID: 34583856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 64.